Real-World Safety Outcomes of Intravitreal Ranibizumab Biosimilar (Razumab) Therapy for Chorioretinal Diseases

INTRODUCTION: To assess the safety profile of the intravitreal ranibizumab biosimilar molecule, Razumab(®) (Intas Pharmaceuticals, Ahmedabad, India) in chorioretinal disorders under real-world conditions. METHODS: This was a multicenter, retrospective chart review which included patients from 15 cen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ophthalmol Ther
Main Authors: Chakraborty, Debdulal, Stewart, Michael W., Sheth, Jay U., Sinha, Tushar K., Boral, Subhendu, Das, Arnab, Mondal, Soumen, Mukherjee, Angshuman
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8079600/
https://ncbi.nlm.nih.gov/pubmed/33864599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40123-021-00345-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados